Skip to main content

Table 6 Estimated effect of the integrated TB/HIV treatment and care intervention, and other covariates, on successful TB treatment (cure or completion) (N = 284)

From: Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study

Characteristic Unadjusted p-value Adjusteda p-value
OR 95% CI OR 95% CI
Integration Intervention
 After 1.77 (0.99, 3.15) 0.05 2.02 (1.11, 3.67) 0.02
 Before 1.00      
Sex
 Female 1.10 (0.61, 1.98) 0.75 1.16 (0.64, 2.13) 0.62
 Male 1.00      
Age
  ≥ 35 years 1.05 (0.59, 1.87) 0.87 1.08 (0.60, 1.95) 0.81
  < 35 years 1.00      
Clinic
 Clinic B 0.57 (0.32, 1.02) 0.06 0.50 (0.27, 0.92) 0.03
 Clinic A 1.00      
TB Site
 Extra-pulmonary 0.77 (0.35, 1.69) 0.52 0.82 (0.37, 1.82) 0.62
 Pulmonary 1.00      
TB Registration Typeb
 Treatment after Default, Failure OR Relapse 0.94 (0.42, 2.10) 0.89 0.99 (0.43, 2.28) 0.98
 New 1.00      
ART started within 8 weeks of TB treatment
 Yes 1.30 (0.72, 2.32) 0.38 1.16 (0.63, 2.13) 0.63
 No 1.00      
  1. OR Odds ratio
  2. aOR estimated by logistic regression modelling, adjusting for remaining variables presented in the table
  3. bRelapse, treatment after default, and failure were collapsed into one category due to collinearity in the model